Activity of boanmycin against colorectal cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

226

HTML

1824

Tables (1-4)

147

Sum=2197

Feb 15, 2001 (publication date) through Apr 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 15, 2001; 7(1): 93-97
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.93

Table 4 Bone marrow nucleated cells in mice bearing CT-26 treated by BAM, 5-FU and MMC

*Drugs were administered at equitoxic doses (1/9 LD50).

^bP < 0.01, vs control group.

Citation: Deng YC, Zhen YS, Zheng S, Xue YC. Activity of boanmycin against colorectal cancer. World J Gastroenterol 2001; 7(1): 93-97
URL: https://www.wjgnet.com/1007-9327/full/v7/i1/93.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i1.93